Financial results - STARPHARM SRL

Financial Summary - Starpharm Srl
Unique identification code: 18428353
Registration number: J15/193/2006
Nace: 4773
Sales - Ron
420.938
Net Profit - Ron
9.824
Employees
3
Open Account
Company Starpharm Srl with Fiscal Code 18428353 recorded a turnover of 2024 of 420.938, with a net profit of 9.824 and having an average number of employees of 3. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Starpharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 231.900 213.354 211.845 223.347 240.218 283.202 287.621 323.062 375.249 420.938
Total Income - EUR 240.603 223.974 222.086 229.654 243.125 284.733 289.033 324.047 375.260 420.970
Total Expenses - EUR 228.071 211.515 211.782 216.238 232.406 269.655 276.635 310.250 358.250 409.071
Gross Profit/Loss - EUR 12.532 12.459 10.304 13.416 10.719 15.078 12.398 13.797 17.009 11.899
Net Profit/Loss - EUR 10.585 10.310 8.606 11.119 8.292 12.810 9.854 10.874 13.667 9.824
Employees 3 3 3 3 3 3 3 3 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 12.8%, from 375.249 euro in the year 2023, to 420.938 euro in 2024. The Net Profit decreased by -3.767 euro, from 13.667 euro in 2023, to 9.824 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Starpharm Srl

Rating financiar

Financial Rating -
STARPHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Starpharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Starpharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Starpharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Starpharm Srl - CUI 18428353

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 3.337 22.506 16.774 12.738 10.496 5.904 1.522 546 10.387 8.331
Current Assets 71.467 49.666 63.960 73.845 79.154 93.655 99.625 111.735 120.895 123.961
Inventories 32.969 33.327 35.165 33.128 39.111 41.389 39.819 45.907 51.525 49.865
Receivables 25.115 8.964 26.461 34.473 28.813 33.974 37.782 44.026 48.836 49.133
Cash 13.383 7.376 2.334 6.244 11.230 18.292 22.024 21.802 20.535 24.963
Shareholders Funds 19.159 18.807 18.470 21.299 20.434 23.657 23.691 24.905 28.642 27.500
Social Capital 45 45 9.851 9.670 9.483 9.303 9.097 9.125 9.097 9.046
Debts 55.645 53.365 62.264 65.284 69.216 75.902 77.456 87.376 102.640 104.793
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 123.961 euro in 2024 which includes Inventories of 49.865 euro, Receivables of 49.133 euro and cash availability of 24.963 euro.
The company's Equity was valued at 27.500 euro, while total Liabilities amounted to 104.793 euro. Equity decreased by -982 euro, from 28.642 euro in 2023, to 27.500 in 2024.

Risk Reports Prices

Reviews - Starpharm Srl

Comments - Starpharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.